Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of Multidrug Resistance in Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 5, 2004, Pages 1778-1787

  Mukhopadhyay, Kasturi ^a   Prasad, Tulika ^a   Saini, Preeti ^a   Pucadyil, Thomas J ^b   Chattopadhyay, Amitabha ^b   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 4 NITROQUINOLINE 1 OXIDE; BENZYL ALCOHOL; ERGOSTEROL; FLUCONAZOLE; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; ITRACONAZOLE; KETOCONAZOLE; PROTEIN CDR1P; RHODAMINE; SPHINGOLIPID; TERBINAFINE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SENSITIVITY; ERG2 GENE; FUNGAL GENE; GROWTH INHIBITION; IN VITRO STUDY; MICROBIAL GROWTH; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, FUNGAL; ERGOSTEROL; FLUORESCENCE POLARIZATION IMMUNOASSAY; FUNGAL PROTEINS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MEMBRANE LIPIDS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; SPHEROPLASTS; SPHINGOLIPIDS;

EID: 2142645082     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.5.1778-1787.2004     Document Type: Article

References (48)

1. Albertson, G. D., M. Niimi, R. D. Cannon, and H. F. Jenkinson. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40:2835-2841.
2. Ansari, S., P. Gupta, S. K. Mahanty, and R. Prasad. 1993. The uptake of amino acids by erg mutants of Candida albicans. J. Med. Vet. Mycol. 31:377-386.
3. Bagnat, M., A. Chang, and K. Simons. 2001. Plasma membrane proton ATPase Pma1p requires raft association for surface delivery in yeast. Mol. Biol. Cell 1 2:4129-4138.
4. Bagnat, M., S. Keranen, A. Shevchenko, A. Shevchenko, and K. Simons. 2000. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc. Natl. Acad. Sci. USA 97:3254-3259.
5. Demeule, M., J. Jodoin, D. Gingras, and R. Beliveau. 2000. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett. 466:219-224.
6. Dickson, R. C., and R. L. Lester. 1999. Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae. Biochim. Biophys. Acta 1438:305-321.
7. Drabikowski, W., E. Lagwinska, and M. G. Sarzala. 1973. Filipin as a fluorescent probe for the location of cholesterol in the membranes of fragmented sarcoplasmic reticulum. Biochim. Biophys. Acta 291:61-70.
8. Espinel-Ingroff, A. 2001. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J. Clin. Microbiol. 39:954-958.
9. Ferte, J. 2000. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur. J. Biochem. 267:277-294.
10. Franz, R., S. L. Kelly, D. C. Lamb, D. E. Kelly, M. Ruhnke, and J. Morschhauser. 1998. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42:3065-3072.
11. Franz, R., M. Ruhnke, and J. Morschhauser. 1999. Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42:453-458.
12. Friend, D. S., and E. L. Bearer. 1981. β-Hydroxysterol distribution as determined by freeze-fracture cytochemistry. Histochem. J. 13:535-546.
13. Hallstrom, T. C., L. Lambert, S. Schorling, E. Balzi, A. Goffeau, and W. S. Moye-Rowley. 2001. Coordinate control of sphingolipid biosynthesis and multidrug resistance in Saccharomyces cerevisiae. J. Biol. Chem. 276:23674-23680.
14. Hitchcock, C. A. 1993. Resistance of Candida albicans to azole antifungal agents. Biochem. Soc. Trans, 21:1039-1047.
15. Kean, L. S., A. M. Grant, C. Angeletti, Y. Mahe, K. Kuchler, R. S. Fuller, and J. W. Nichols. 1997. Plasma membrane translocation of fluorescent-labeled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3. J. Cell Biol. 138:255-270.
16. Kohli, A., Smriti, K. Mukhopadhyay, A. Rattan, and R. Prasad. 2002. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob. Agents Chemother. 46:1046-1052.
17. Koppel, D. E., M. P. Sheetz, and M. Schindler. 1980. Lateral diffusion in biological membranes: a normal-mode analysis of diffusion on a spherical surface. Biophys. J. 30:187-192.
18. Lavie, Y., G. Fiucci, and M. Liscovitch. 1998. Up-regulation of caveolae and caveolar constituents in multi-drug-resistant cancer cells. J. Biol. Chem. 273:32380-32383.
19. Lavie, Y., and M. Liscovitch. 2001. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistance cancer cells and their functional consequences. Glycoconjugate J. 17:253-259.
20. Lester, R. L., and R. C. Dickson. 1993. Sphingolipids with inositolphosphate-containing head groups. Adv. Lipid Res. 26:253-274.
21. Liscovitcb, M., and Y. Lavie. 2000, Multidrug resistance: a role for cholesterol efflux pathways? Trends Biochem. Sci. 25:530-537.
22. Loffler, J., H. Einsele, H. Hebart, U. Schumacher, C. Hrastnik, and G. Daum. 2000. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol. Lett. 185:59-63.
23. Luker, G. D., C. M. Pica, A. S. Kumar, D. F. Covey, and D. Piwnica-Worms. 2000. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. Biochemistry 39:7651-7661.
24. Maesaki, S., P. Marichal, H. V. Bossche, D. Sanglard, and S. Kohno. 1999. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J. Antimicrob. Chemother. 44:27-31.
25. Mandala, S. M., R. A. Thornton, M. Rosenbach, J. Milligan, M. Garcia-Calvo, H. G. Bull, and M. B. Kurtz. 2002. Khafrefungin, a novel inhibitor of sphingolipid synthesis. J. Biol. Chem. 272:32709-32714.
26. Maxfield, F. R. 2002. Plasma membrane microdomains. Curr. Opin. Cell Biol. 14:483-487.
27. Morschhauser, J. 2002. The genetic basis of fluconazole resistance development in Candida albicans. Biochim. Biophys. Acta 1587:240-248.
28. Mukhopadhyay, K., A. K. Kohli, and R. Prasad. 2002. Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob. Agents Chemother. 46:3695-3705.
29. Nakamura, K., M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottignies, B. C. Monk, A. Goffeau, and R. D. Cannon. 2002. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45:3366-3374.
30. Odds, F. C. 1988. Candida and candidosis: a review and bibliography. Balliére Tindall, London, England.
31. Pao, S. S., I. T. Paulsen, and M. H. Saier, Jr. 1998. Major facilitator super-family. Microbiol. Mol. Biol. Rev. 62:1-34.
32. Parks, L. W., and W. M. Casey. 1995. Physiological implications of sterol biosynthesis in yeast. Annu. Rev. Microbiol. 49:95-116.
33. Pesti, M., J. M. Campbell, and J. F. Peberdy. 1981. Alteration of ergosterol content and chitin synthase activity in Candida albicans. Curr. Microbiol. 5:187-190.
34. Regev, R., Y. G. Assaraf, and G. D. Eytan. 1999. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur. J. Biochem. 259:18-24.
35. Seitsma, H., R. J. Veldman, and J. W. Kok. 2001. The involvement of sphingolipids in multidrug resistance. J. Membr. Biol. 181:153-162.
36. Shukla, S., P. Saini, Smriti, S. Jha, S. V. Ambudkar, and R. Prasad. 2003. Functional characterization of Candida albicans ABC drug transporter Cdr1p. Eukaryot. Cell 2:1361-1375.
37. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387:569-572,
38. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 1:31-39.
39. Sinicrope, F. A., P. K. Dudeja, B. M. Bissonnette, A. R. Safa, and T. A. Brasitus. 1992. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J. Biol. Chem. 267:24995-25002.
40. Smriti, S. Krishnamurthy, B. L. Dixit, C. M. Gupta, S. Milewski, and R. Prasad. 2002. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators. Yeast 19:303-318.
41. Smriti, S. S. Krishnamurthy, and R. Prasad. 1999. Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans. FEMS Microbiol. Lett. 173:475-481.
42. Storey, M. K., D. M. Byers, H. W. Cook, and N. D. Ridgway. 1998. Cholesterol regulates oxysterol binding protein (OSBP) phosphorylation and Golgi localization in Chinese hamster ovary cells: correlation with stimulation of sphingomyelin synthesis by 25-hydroxycholesterol. Biochem. J. 336:247-256.
43. Swain, E., K. Baudry, J. Stukey, V. McDonough, M. Germann, and J. T. Nickels, Jr. 2002. Sterol-dependent regulation of sphingolipid metabolism in Saccharomyces cerevisiae. J. Biol. Chem. 277:26177-26184.
44. Wachtler, V., S. Rajagopalan, and M. K. Balasubramanian. 2003. Sterol-rich plasma membrane domains in the fission yeast Schizosaccharomyces pombe. J. Cell Sci. 116:867-874.
45. White, T. C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increased azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
46. White, T. C., S. Holleman, F. Dy, L. F. Mirels, and D. A. Stevens. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46:1704-1713.
47. Worgall, T. S., R. A. Johnson, T. Seo, H. Gierens, and R. J. Deckelbaum. 2002. Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism. J. Biol. Chem. 277:3878-3885.
48. Xu, X., R. Bittman, G. Duportail, D. Heissler, C. Vilcheze, and E. London. 2001. Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). J. Biol. Chem. 276:33540-33546.